---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-224944"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2023-08-30T23:59:59+00:00"
generated_at: "2026-06-11T02:02:36.548481+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Mirum amends severance plan; expands CEO/NEO change-in-control benefits

## Summary
- CEO Peetz: 12mo base salary + 12mo equity vesting (non-CIC); 24mo salary + 200% bonus + full vesting (CIC).
- NEOs Longpre, Radovich, Vig: 9mo salary + 12mo vesting (non-CIC); 18mo salary + 150% bonus + full vesting (CIC).
- Plan amendment removes automatic sunset provision; administrative changes made.
- New participation agreements with each NEO reflect modified benefits.

## SEC filing metadata
- accession: 0001193125-23-224944
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2023-08-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000119312523224944/0001193125-23-224944-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000119312523224944/d549647d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-224944
- JSON: https://secwatch.observer/filing/0001193125-23-224944.json
- Plain text: https://secwatch.observer/filing/0001193125-23-224944.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.